Positive antinuclear antibodies were found in 13/24 (54%) patients with dermatomyositis without malignancy, but they were found in only 2/12 (17%) of those with malignancy (p<0 03). The low incidence of antinuclear antibodies in dermatomyositis with malignancy suggests the presence of a different serological background from that in the dermatomyositis without malignancy. This conclusion supports the view that a distinct subset of dermatomyositis exists-dermatomyositis with malignancy. MASAHIKO Allopurinol (18 mg/kg daily for five days before killing) in drinking water had no effect on acute inflammation induced by the subplantar injection of carrageenan in the rat paw. Similarly, allopurinol injected directly into rat air pouches (10-250 mg/kg daily for three days before slaughter) had no effect on the acute (24 hour) or chronic (seven day) phases of carrageenan induced inflammation in this model as measured by total white cell count. Possibly, the use of a low molecular weight inhibitor such as allopurinol, with relatively fast renal clearance, resulted in incomplete inhibition of the enzyme for at least part of the duration of the experiment. We therefore used a more direct method to test the role of xanthine oxidase in inflammation by preventing the synthesis of active enzyme.
Tungsten mediated inhibition of molybdenum uptake produces a profound reduction in the activity of the enzyme xanthine oxidase, one of only three molybdenum dependent enzymes found in rats. 6 7 We found that rats fed a diet low in molybdenum and supplemented with tungsten showed no change in the progress of carrageenan induced paw oedema when compared with rats fed a matched diet without tungsten supplementation and with defined molybdenum content. Similarly, there was no change in the progress or extent of Mycobacterium butyricum induced adjuvant arthritis (disease assessed by a joint scoring system and total body weight variation).
In conclusion, it seems unlikely that xanthine oxidase system plays a significant part in these models of inflammation.
We have previously proposed that the arthritic component of adjuvant disease may be exacerbated by episodes of ischaemiareperfusion injury and that this may be a feature of chronic synovitis in humans. Although these experiments do not support that hypothesis, they do not exclude other ischaemia-reperfusion mediated sources of injury or the effectiveness of trace amounts of residual xanthine oxidase. The immunological component of adjuvant disease is so powerful a drive in the progress of the arthritis that this is probably not the most sensitive of models for testing the contribution of a non-immunological variable. Ischaemia-reperfusion injury has not been proposed as a contributory factor in the other models of inflammation we used, but the involvement of endothelial cells in acute inflammation is well known and the aim of these experiments was to assess the contribution of xanthine oxidase in the endothelial cell response. Allopurinol is apparently ineffective in these models either because xanthine oxidase inhibition is unimportant or because a greater degree of inhibition is required. 
